Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ascendis Pharma A/S

171.72
-0.6300-0.37%
Post-market: 171.720.00000.00%16:37 EDT
Volume:231.95K
Turnover:39.99M
Market Cap:10.37B
PE:-27.28
High:174.11
Open:172.59
Low:170.69
Close:172.35
Loading ...

Ascendis Pharma A/S Announces Share Repurchase Program & Net Settlement Of Certain Rsus

Reuters
·
13 Feb

Stock Track | Ascendis Pharma Soars 6% After Hours on Q4 Beat, Buyback Plan

Stock Track
·
13 Feb

Ascendis Pharma announces share repurchase program, settlement of certain RSUs

TIPRANKS
·
13 Feb

Ascendis Pharma Q4 Loss Narrows, Revenue Rises -- Shares Up After Hours

MT Newswires Live
·
13 Feb

Stock Track | Ascendis Pharma Soars 5.87% After Beating Q4 Estimates on Strong Sales Growth

Stock Track
·
13 Feb

Ascendis Pharma Q4 2024 GAAP EPS €(0.64) Beats €(1.07) Estimate, Sales €173.916M Beat €111.178M Estimate

Benzinga
·
13 Feb

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
12 Feb

Ascendis Pharma Price Target Maintained With a $170.00/Share by Cantor Fitzgerald

Dow Jones
·
11 Feb

Ascendis Pharma A/S expected to post a loss of €1.08 a share - Earnings Preview

Reuters
·
11 Feb

Morgan Stanley Remains a Hold on Ascendis Pharma (ASND)

TIPRANKS
·
10 Feb

Ascendis Pharma a/S : Morgan Stanley Raises Target Price to $175 From $167

THOMSON REUTERS
·
04 Feb

Ascendis Pharma A/S expected to post a loss of €1.14 a share - Earnings Preview

Reuters
·
03 Feb

European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading

MT Newswires Live
·
01 Feb

Exploring High Growth Tech Stocks In January 2025

Simply Wall St.
·
30 Jan

Ascendis Pharma Is Maintained at Overweight by JP Morgan

Dow Jones
·
29 Jan

JPMorgan ups Ascendis target, sees buying opportunity on pullback

TIPRANKS
·
29 Jan

J.P. Morgan Sticks to Their Buy Rating for Ascendis Pharma (ASND)

TIPRANKS
·
29 Jan

Is Ascendis Pharma (ASND) the High Growth International Stock to Invest in Now?

Insider Monkey
·
23 Jan

European Equities Traded in the US as American Depositary Receipts Edge Lower in Wednesday Trading

MT Newswires Live
·
23 Jan

BioMarin Pharmaceutical Sues Ascendis Pharma for Patent Infringement in Germany

MT Newswires Live
·
14 Jan